Company / R&D per Share
Health Catalyst, Inc. R&D per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.13
FY2025
5-year range
$1.02 / $1.30
FY2021-FY2025
Trend
-12.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share has fluctuated over the past 7 years, ranging from $1.02 in FY2022 to $5.87 in FY2019.
Based on SEC 10-K filings.
1.13 in FY2025 with a 5-year CAGR of +1.5%.
Remained stable around $1.13 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +3.7%
- 5-Year CAGR
- +1.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share decreased 12.6% year-over-year.
- Peak r&d per share was recorded in FY2019.
- Lowest r&d per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 1.03 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.13 | -12.6% |
| FY2024 | $1.30 | +14.4% |
| FY2023 | $1.14 | +11.6% |
| FY2022 | $1.02 | -4.6% |
| FY2021 | $1.07 | +1.3% |
| FY2020 | $1.05 | -82.1% |
| FY2019 | $5.87 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026